Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Voting Rights Announcement: Bayer Aktiengesellschaft
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
05.12.2025 / 10:33 CET/CEST
Dissemination of a Voting Rights Announcement transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.
Notification of Major Holdings
1. Details of issuer
Name:
Bayer Aktiengesellschaft
Street:
Kaiser-Wilhelm-Allee 1
Postal code:
51373
City:
Leverkusen Germany
Legal Entity Identifier (LEI):
549300J4U55H3WP1XT59
2. Reason for notification
Acquisition/disposal of shares with voting rights
X
Acquisition/disposal of instruments
Change of breakdown of voting rights
Other reason:
3. Details of person subject to the notification obligation
Legal entity: The Goldman Sachs Group, Inc. City of registered office, country: Wilmington, DE, United States of America (USA)
4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
5. Date on which threshold was crossed or reached:
28 Nov 2025
6. Total positions
% of voting rights attached to shares (total of 7.a.)
% of voting rights through instruments (total of 7.b.1 + 7.b.2)
Total of both in % (7.a. + 7.b.)
Total number of voting rights pursuant to Sec. 41 WpHG
New
0.36 %
5.05 %
5.41 %
982424082
Previous notification
0.19 %
4.95 %
5.14 %
/
7. Details on total positions a. Voting rights attached to shares (Sec. 33, 34 WpHG)
ISIN
Absolute
In %
Direct (Sec. 33 WpHG)
Indirect (Sec. 34 WpHG)
Direct (Sec. 33 WpHG)
Indirect (Sec. 34 WpHG)
US0727303028
0
371050
0 %
0.04 %
DE000BAY0017
0
3177832
0 %
0.32 %
Total
3548882
0.36 %
b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
Type of instrument
Expiration or maturity date
Exercise or conversion period
Voting rights absolute
Voting rights in %
Right To Recall
Open
988009
0.10 %
Right Of Use
Open
1923353
0.20 %
Swap
15.12.2026
249954
0.03 %
Call Warrant
31.12.2030
443865
0.05 %
Call Option
14.02.2029
14858693
1.51 %
Forward
10.12.2025
630
0.00006 %
Total
18464504
1.88 %
b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
Type of instrument
Expiration or maturity date
Exercise or conversion period
Cash or physical settlement
Voting rights absolute
Voting rights in %
Swap
21.11.2035
Cash
8683626
0.88 %
Call Option
10.04.2037
Cash
7369959
0.75 %
Put Option
17.12.2027
Physical
8242838
0.84 %
Call Warrant
31.12.2030
Cash
2100763
0.21 %
Put Option
16.12.2033
Cash
2061431
0.21 %
Future
16.12.2033
Cash
2141178
0.22 %
Forward
20.03.2026
Cash
551518
0.06 %
Put Warrant
20.03.2026
Physical
9029
0.0009 %
Total
31160342
3.17 %
8. Information in relation to the person subject to the notification obligation
Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).
X
Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:
Name
% of voting rights (if at least 3% or more)
% of voting rights through instruments (if at least 5% or more)
Total of both (if at least 5% or more)
The Goldman Sachs Group, Inc.
%
%
%
GSAM Holdings LLC
%
%
%
Goldman Sachs Asset Management Holdings LLC
%
%
%
Goldman Sachs Asset Management UK Holdings I Ltd
%
%
%
Goldman Sachs Asset Management UK Holdings II Ltd
%
%
%
Goldman Sachs Asset Management Holdings I B.V. / Goldman Sachs Asset Management Holdings II B.V.
%
%
%
Goldman Sachs Asset Management Holdings B.V.
%
%
%
Goldman Sachs Asset Management International Holdings B.V.
%
%
%
Goldman Sachs Asset Management B.V.
%
%
%
-
%
%
%
The Goldman Sachs Group, Inc.
%
%
%
GS Global Markets, Inc.
%
%
%
Goldman Sachs Finance Corp International Ltd
%
%
%
-
%
%
%
The Goldman Sachs Group, Inc.
%
%
%
Goldman Sachs (UK) L.L.C.
%
%
%
Goldman Sachs Group UK Limited
%
%
%
Goldman Sachs International Bank
%
%
%
-
%
%
%
The Goldman Sachs Group, Inc.
%
%
%
Goldman Sachs Bank USA
%
%
%
Goldman Sachs Bank Europe SE
%
%
%
-
%
%
%
The Goldman Sachs Group, Inc.
%
%
%
Goldman, Sachs & Co. Wertpapier GmbH
%
%
%
-
%
%
%
The Goldman Sachs Group, Inc.
%
%
%
GS Finance Corp.
%
%
%
-
%
%
%
The Goldman Sachs Group, Inc.
%
%
%
Goldman Sachs (UK) L.L.C.
%
%
%
Goldman Sachs Group UK Limited
%
%
%
Goldman Sachs International
%
%
%
-
%
%
%
The Goldman Sachs Group, Inc.
%
%
%
GSAM Holdings LLC
%
%
%
Goldman Sachs Asset Management, L.P.
%
%
%
-
%
%
%
The Goldman Sachs Group, Inc.
%
%
%
Folio Financial, Inc.
%
%
%
Folio Investments, Inc.
%
%
%
-
%
%
%
The Goldman Sachs Group, Inc.
%
%
%
Murray Street Corporation
%
%
%
Sphere Fundo De Investimento Multimercado - Investimento No Exterior Credito Privado
%
%
%
Sphere Fund
%
%
%
-
%
%
%
The Goldman Sachs Group, Inc.
%
%
%
Goldman Sachs & Co. LLC
%
%
%
-
%
%
%
The Goldman Sachs Group, Inc.
%
%
%
Goldman Sachs Do Brasil Banco Multiplo S/A
%
%
%
9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)
Date of general meeting:
Holding total positions after general meeting (6.) after annual general meeting:
Proportion of voting rights
Proportion of instruments
Total of both
%
%
%
10. Other explanatory remarks:
Date
04 Dec 2025
05.12.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (47.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38.9%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.6%);
- other (0.7%).
Net sales are distributed geographically as follows: Germany (5.2%), Switzerland (1.2%), Europe/Middle East/Africa (23.6%), the United States (31.7%), North America (3.6%), China (7.7%), Asia/Pacific (9.6%), Brazil (9.3%) and Latin America (8.1%).
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution